Acción PCSA PROCESSA PHARMACEUTICALS, INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Processa Pharmaceuticals, Inc.

Acciones

PCSA

US74275C3043

Mercado cerrado - Nasdaq
Otros sitios de cotización
 22:00:00 26/04/2024 		Varia. Cinco días. Varia. 1 de enero.
2,15 USD -11,52 % Gráfico intradía de Processa Pharmaceuticals, Inc. +36,08 % -67,87 %
26/04 Principales caídas antes de la apertura del mercado MT
25/04 Principales ganancias del mediodía MT

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Top Premarket Decliners
Top Midday Gainers
Processa Pharmaceuticals Presents Two Abstracts at the AACR Annual Meeting 2024 Including New Data on the NGC-Cap Phase 1b Trial
Processa Pharmaceuticals, Inc. Presents Two Abstracts At the AACR Annual Meeting 2024 Including New Data on the NGC-Cap Phase 1B Trial
Processa Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference
Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual Meeting
Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference
Processa Pharmaceuticals to Present at The Winter Wrap-Up MicroCap Rodeo Winter 2024 Virtual Conference
Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule
Processa Pharmaceuticals Announces Closing of $7.0 Million Public Offering
Nasdaq Stocks Above $2 to Watch Now! LVTX, INBS, IKT, PCSA, DYAI
Sector Update: Health Care Stocks Stronger Late Afternoon
Top Midday Decliners
Sector Update: Health Care Stocks Higher Friday Afternoon
Processa Pharmaceuticals Prices $7 Million Common Stock Offering
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
Sector Update: Health Care Stocks Softer Late Afternoon
Top Midday Gainers
Processa Pharmaceuticals Shares More Than Double After Completing Safety Evaluation of Cancer Treatment
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción PCSA
  4. Noticias Processa Pharmaceuticals, Inc.
  5. Otros idiomas